A Comparison of Two Strategies for Converting to Adalimumab Biosimilarsa

Sara J Erickson, Heather D H Rovey, Cassandra L Ramel, Bryan J Buechel, Kelci A Swenson, Anna S Bartoo, John M Davis III

Open source

DOI: 10.1093/ajhp/zxag384
Published: 2026-11-07
Container: American Journal of Health-System Pharmacy
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/ajhp/zxag384,
  title = {A Comparison of Two Strategies for Converting to Adalimumab Biosimilarsa},
  author = {Sara J Erickson and Heather D H Rovey and Cassandra L Ramel and Bryan J Buechel and Kelci A Swenson and Anna S Bartoo and John M Davis III},
  year = {2026},
  journal = {American Journal of Health-System Pharmacy},
  doi = {10.1093/ajhp/zxag384},
  url = {https://doi.org/10.1093/ajhp/zxag384}
}

RIS

TY  - JOUR
TI  - A Comparison of Two Strategies for Converting to Adalimumab Biosimilarsa
AU  - Sara J Erickson
AU  - Heather D H Rovey
AU  - Cassandra L Ramel
AU  - Bryan J Buechel
AU  - Kelci A Swenson
AU  - Anna S Bartoo
AU  - John M Davis III
PY  - 2026
JO  - American Journal of Health-System Pharmacy
DO  - 10.1093/ajhp/zxag384
UR  - https://doi.org/10.1093/ajhp/zxag384
ER  -

APA

Erickson, S. J., Rovey, H. D. H., Ramel, C. L., Buechel, B. J., Swenson, K. A., Bartoo, A. S., & III, J. M. D. (2026). A Comparison of Two Strategies for Converting to Adalimumab Biosimilarsa. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxag384

Source records

crossref · retrieved 2026-11-09T14:57:13.624Z